Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051.
- Status
- COMPLETED
- Phase
- PHASE1
Safety Tolerability and Pharmacokinetic of BI 409306
- Status
- COMPLETED
- Phase
- PHASE1
Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Drug Drug Interaction of BI 201335 and Tenofovir
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)
- Status
- TERMINATED
- Phase
- PHASE1
Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon
- Status
- COMPLETED
- Phase
- PHASE1
Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monotherapy Dose Finding With BI 847325 in Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
BIBW 2992 (Afatinib) for the Treatment of Patients With HER2-positive, Hormone-refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types
- Status
- COMPLETED
- Phase
- PHASE1
Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1